Form 4 for MIRM Mirum Pharmaceuticals, Inc.
Accepted 2024-01-09 00:00:00 ET · period of report 2024-01-06 · accession 0001415889-24-000880 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-01-09 | 2024-01-08 | MIRM | Howe Jolanda | SVP, Gbl Ctrl | S - Sale+OE | $28.04 | -528 | 722 | -42% | -$14.8K |
| D | 2024-01-09 | 2024-01-06 | MIRM | Howe Jolanda | SVP, Gbl Ctrl | M - OptEx | — | +1,250 | 1,250 | New | — |
| D | 2024-01-09 | 2024-01-06 | MIRM | Howe Jolanda | SVP, Gbl Ctrl | M - OptEx | $0.00 | -1,250 | 1,250 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-08 | S | D | 528 | $28.04 | 722 | D | — | — | |
| 2 | Common | Common Stock | 2024-01-06 | M | A | 1,250 | — | 1,250 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer). |
| 3 | Derivative | Restricted Stock Units | 2024-01-06 | M | D | 1,250 | $0.00 | 1,250 | D | — · — to — | 1,250 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer). (F3) The restricted stock units vest in a series of three successive equal annual installments beginning January 6, 2023. 1,250 shares vested on each of January 6, 2023 and January 6, 2024 and the remaining 1,250 shares will vest on January 6, 2025. |